A buying signal is a reason to investigate.
Medical device buying signals are observable changes that may make a product or workflow conversation more relevant. Their value depends on the product, account, timing, and evidence. A signal is not a declaration that an organization intends to buy from you.
Start with a narrow research question: which facilities could plausibly benefit from the workflow you support, and what changed that makes a conversation useful now? That gives a rep a testable hypothesis instead of a generic lead score.
What changed?
A dated source describes an event.
Does it hold up?
Check entity, location, date, and context.
Does it matter?
Verify workflow, stage, and responsibility.
What comes next?
Agree on a next step, or close the question.
Five signals worth checking in context.
| Observation | Possible relevance | Verify next |
|---|---|---|
| New facility or expansion | A location or capacity plan may change workflows | What is still being scoped, and what is already selected? |
| New service or program | A product-relevant workflow is being described | Who is responsible for the program and its current systems? |
| Named procurement notice | A published requirement has a defined process | What stage, scope, deadlines, and eligibility apply? |
| Relevant team change | A new person may own a workflow question | Does their role include evaluation or purchasing responsibility? |
| Specific technology announcement | An adjacent workflow may deserve research | Does the change create a gap, resolve one, or close the opportunity? |
Read the same kind of change through different product lenses.
The examples below are invented to illustrate the method. They are not researched accounts or live opportunities. Switch categories to see how the supported observation, unknowns, and first question change.
One change. A more useful conversation.
Choose a category to see how an observation becomes a question a rep can verify.
Imaging program expansion
- Observed signal
- An organization announces an additional outpatient imaging location.
- What it supports
- A new location and an imaging program are publicly described.
- Still unknown
- Equipment already selected, procurement stage, vendor access, and current workflow.
- A useful first question
- How is the new site’s imaging workflow being planned, and who owns the evaluation?
Use a source for the job it can actually do.
Provider announcements, facility websites, public records, and permitted business sources can establish specific dated observations. Preserve the original URL, entity, location, observation date, and a short factual summary before adding your interpretation.
SAM.gov publishes federal procurement notices, including notices at different stages of the process. Read the notice type and requirements; an award notice and an open solicitation are different events.
CMS Care Compare and the Provider Data Catalog provide publicly reported provider information and quality data. Use each field according to its definition. It is not a list of organizations ready to purchase equipment.
FDA AccessGUDID provides device-identification information. A device-catalog entry is not evidence of installation at a particular hospital or clinic.
Turn the signal into a five-line account brief.
- Observation: what the source actually says.
- Relevance: why that fact might matter for your product’s supported workflow.
- Uncertainty: current systems, project stage, access, or authority that remains unknown.
- Question: one respectful way to test the hypothesis.
- Next action: research further, ask for clarification, revisit later, or suppress.
Keep this brief attached to the source. If an account is disqualified, record the reason so the same public announcement does not keep putting it back into the queue.
Know when the signal should stop the sales motion.
A published project can reveal that the equipment decision is already closed. An affiliation change can point to a different decision level. A stale announcement may describe work completed long ago. Contradictory evidence should reduce confidence, not disappear from the brief.
Use the evidence to improve the conversation and respect the organization’s process. Avoid claims about hidden clinical need, budgets, utilization, contracts, or purchase intent from a few public keywords.
The best research output may be “do not pursue.” A clear suppressor saves rep time and leaves a more credible record than an inflated intent score.
Measure whether the research changes field decisions.
For a pilot, use one product category and a territory slice the rep understands. Track accepted findings, rejected hypotheses, useful discovery questions, qualified next steps, and reasons to suppress. Keep search traffic and form requests separate from verified commercial demand.
For ownership and coverage decisions, use the territory alignment field guide. For the broader account-research method, read medical device sales intelligence.
Start with one useful account question.
Tell us the device category, territory, and account question you want to test.